Christopher D Alafi - Net Worth and Insider Trading
Christopher D Alafi Net Worth
The estimated net worth of Christopher D Alafi is at least $760 Million dollars as of 2025-04-30. Christopher D Alafi is the Director of Intra-Cellular Therapies Inc and owns about 5,762,746 shares of Intra-Cellular Therapies Inc (ITCI) stock worth over $760 Million. Details can be seen in Christopher D Alafi's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher D Alafi has not made any transactions after 2020-09-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher D Alafi
Christopher D Alafi Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher D Alafi owns 2 companies in total, including Intra-Cellular Therapies Inc (ITCI) , and Stereotaxis Inc (STXS) .
Click here to see the complete history of Christopher D Alafi’s form 4 insider trades.
Insider Ownership Summary of Christopher D Alafi
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| ITCI | Intra-Cellular Therapies Inc | 2020-09-14 | director & 10 percent owner |
| STXS | Stereotaxis Inc | 2004-08-11 | director & 10 percent owner |
Christopher D Alafi Latest Holdings Summary
Christopher D Alafi currently owns a total of 1 stock. Christopher D Alafi owns 5,762,746 shares of Intra-Cellular Therapies Inc (ITCI) as of September 14, 2020, with a value of $760 Million.
Latest Holdings of Christopher D Alafi
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ITCI | Intra-Cellular Therapies Inc | 2020-09-14 | 5,762,746 | 131.87 | 759,933,315 |
Holding Weightings of Christopher D Alafi
Christopher D Alafi Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher D Alafi has made a total of 2 transactions in Intra-Cellular Therapies Inc (ITCI) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Intra-Cellular Therapies Inc is the acquisition of 49,500 shares on September 14, 2020, which cost Christopher D Alafi around $1 Million.
Insider Trading History of Christopher D Alafi
- 1
Christopher D Alafi Trading Performance
GuruFocus tracks the stock performance after each of Christopher D Alafi's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher D Alafi is 5.62%. GuruFocus also compares Christopher D Alafi's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher D Alafi within 3 months outperforms 7 times out of 14 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christopher D Alafi's insider trading performs compared to the benchmark.
Performance of Christopher D Alafi
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.76 | | | | | |
| Relative Return to S&P 500(%) | -5.92 | | | | | |
Christopher D Alafi Ownership Network
Ownership Network List of Christopher D Alafi
Ownership Network Relation of Christopher D Alafi
Christopher D Alafi Owned Company Details
What does Intra-Cellular Therapies Inc do?
Who are the key executives at Intra-Cellular Therapies Inc?
Christopher D Alafi is the director & 10 percent owner of Intra-Cellular Therapies Inc. Other key executives at Intra-Cellular Therapies Inc include director & Chairman & President & CEO Sharon Mates , SVP and General Counsel Michael Halstead , and EVP & Chief Commercial Officer Mark Neumann .
Intra-Cellular Therapies Inc (ITCI) Insider Trades Summary
Over the past 18 months, Christopher D Alafi made no insider transaction in Intra-Cellular Therapies Inc (ITCI). Other recent insider transactions involving Intra-Cellular Therapies Inc (ITCI) include a net sale of 698,809 shares made by Sharon Mates , a net sale of 181,827 shares made by Michael Halstead , and a net sale of 103,985 shares made by Suresh K. Durgam .
In summary, during the past 3 months, insiders sold 0 shares of Intra-Cellular Therapies Inc (ITCI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,204,535 shares of Intra-Cellular Therapies Inc (ITCI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,204,535 shares.
Intra-Cellular Therapies Inc (ITCI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intra-Cellular Therapies Inc Insider Transactions
Christopher D Alafi Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher D Alafi. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Christopher D Alafi's mailing address is: Berkeley Ca 94707.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
